How is the Esperion Therapeutics Inc. today?

The Esperion Therapeutics Inc. today is trading in the green, up by 0.95% at 1.06.

What is Esperion Therapeutics Inc. Annual Revenue?

Esperion Therapeutics Inc. Annual Revenue rose 185.66%, in the last year to $332.31 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Esperion Therapeutics Inc. Annual Net Profit?

Esperion Therapeutics Inc. Annual Net Profit rose 75.27% in the last year to $51.74 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Esperion Therapeutics Inc. Price to Earning Ratio?

Esperion Therapeutics Inc. Price to Earning Ratio is -1.37, which is negative.

What is Esperion Therapeutics Inc. Stock Price?

Esperion Therapeutics Inc. Stock Price fell 52.68% and underperformed its sector by 84.89% in the past year.

What is Esperion Therapeutics Inc. Quarterly Revenue?

Esperion Therapeutics Inc. Quarterly Revenue fell 52.81% YoY to $65 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Esperion Therapeutics Inc. Quarterly Net profit?

Esperion Therapeutics Inc. Quarterly Net profit fell 166.3% YoY to $40.46 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is Esperion Therapeutics Inc. Mutual Fund Holding?

Esperion Therapeutics Inc. Mutual Fund Holding decreased by 4.63% in the last quarter to 34.25.

What is Esperion Therapeutics Inc. Promoter Share Holding?

Esperion Therapeutics Inc. Promoter Share Holding increased by 4.63% in the most recent quarter to 10.42%.

What is Esperion Therapeutics Inc. Interest Coverage Ratio?

Esperion Therapeutics Inc. Interest Coverage Ratio is 0.13, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Esperion Therapeutics Inc. Institutional Holding?

Esperion Therapeutics Inc. Institutional Holding decreased by 7.26% in the last quarter to 58.6.

Esperion Therapeutics Inc. XNAS: ESPR

Esperion Therapeutics Inc. Live Share Price Today, Share Analysis and Chart

Name: Esperion Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Esperion Therapeutics Inc.
Rating: 1.11483325
Author: Trendlyne DVM scores

about

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the bus...

1.06 0.01 (0.95%)

73.10% Fall from 52W High

1.6M XNAS Volume

XNAS 04 Jun, 2025 11:25 AM (EDT)

Not Eligible

-

Expensive Valuation

14.8 / 100

Technically Bearish

29.8 / 100

6

1Yr Price target upside is 446%

7 analysts

Esperion Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Esperion Therapeutics Inc. FAQ

How is Esperion Therapeutics Inc. today?

Esperion Therapeutics Inc. today is trading in the green, and is up by 0.95% at 1.06.

How has Esperion Therapeutics Inc. performed historically?

Esperion Therapeutics Inc. is currently trading up 0.95% on an intraday basis. In the past week the stock rose 29.27%. stock has been down -32.91% in the past quarter and fell -52.68% in the past year. You can view this in the overview section.